
Fibrinolytic Inhibitors in the Management of Bleeding Disorders
A description of the mechanism of action of fibrinolytic inhibitors and their use in the treatment of inherited bleeding disorders
Year: 2018
Language: English
Author(s): Jenny Goudemand, Manuel Carcao
Format: Document
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese
Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of how and why inhibitors form, reviews the established approaches to managing inhibitors, and looks ahead to some potential future developments in the field.

A description of the mechanism of action of fibrinolytic inhibitors and their use in the treatment of inherited bleeding disorders

A discussion of the mild forms of hemophilia A and hemophilia B, from epidemiology and molecular basis, via diagnosis, to

Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an

This paper describes physiotherapy management following acute muscle bleeds and the assessment and treatment of muscle imbalances that may occur

This report reviews the spectrum of indications of desmopressin in the treatment of bleeding disorders.

This monograph highlights the prevalence and devastating impact of pain in hemophilia patients, reviews currently available treatment options, and identifies